188 related articles for article (PubMed ID: 37285658)
1. Investigation of excipients impact on polysorbate 80 degradation in biopharmaceutical formulation buffers.
Bai L; Zhang Y; Zhang C; Lu Y; Li Z; Huang G; Meng B
J Pharm Biomed Anal; 2023 Sep; 233():115496. PubMed ID: 37285658
[TBL] [Abstract][Full Text] [Related]
2. Impact of mono- and poly-ester fractions on polysorbate quantitation using mixed-mode HPLC-CAD/ELSD and the fluorescence micelle assay.
Lippold S; Koshari SHS; Kopf R; Schuller R; Buckel T; Zarraga IE; Koehn H
J Pharm Biomed Anal; 2017 Jan; 132():24-34. PubMed ID: 27693757
[TBL] [Abstract][Full Text] [Related]
3. Degradation of polysorbates 20 and 80 catalysed by histidine chloride buffer.
Brovč EV; Mravljak J; Šink R; Pajk S
Eur J Pharm Biopharm; 2020 Sep; 154():236-245. PubMed ID: 32693155
[TBL] [Abstract][Full Text] [Related]
4. Acidic and alkaline hydrolysis of polysorbates under aqueous conditions: Towards understanding polysorbate degradation in biopharmaceutical formulations.
Dwivedi M; Buske J; Haemmerling F; Blech M; Garidel P
Eur J Pharm Sci; 2020 Mar; 144():105211. PubMed ID: 31931121
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of a selective marker-based quantification of polysorbate 20 in biopharmaceutical formulations using UPLC QDa detection.
Evers DH; Schultz-Fademrecht T; Garidel P; Buske J
J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Nov; 1157():122287. PubMed ID: 33069954
[TBL] [Abstract][Full Text] [Related]
6. Impact of Stainless Steel Exposure on the Oxidation of Polysorbate 80 in Histidine Placebo and Active Monoclonal Antibody Formulation.
Gopalrathnam G; Sharma AN; Dodd SW; Huang L
PDA J Pharm Sci Technol; 2018; 72(2):163-175. PubMed ID: 29343621
[TBL] [Abstract][Full Text] [Related]
7. Polysorbates versus Hydroxypropyl Beta-Cyclodextrin (HPβCD): Comparative Study on Excipient Stability and Stabilization Benefits on Monoclonal Antibodies.
Zhang H; Hong S; Tan SSK; Peng T; Goh LYH; Lam KH; Chow KT; Gokhale R
Molecules; 2022 Oct; 27(19):. PubMed ID: 36235038
[TBL] [Abstract][Full Text] [Related]
8. Characterization and stability study of polysorbate 20 in therapeutic monoclonal antibody formulation by multidimensional ultrahigh-performance liquid chromatography-charged aerosol detection-mass spectrometry.
Li Y; Hewitt D; Lentz YK; Ji JA; Zhang TY; Zhang K
Anal Chem; 2014 May; 86(10):5150-7. PubMed ID: 24749737
[TBL] [Abstract][Full Text] [Related]
9. Intra-Micellar and Extra-Micellar Oxidation in Phosphate and Histidine Buffers Containing Polysorbate 80.
Peters BH; Wei Y; Middaugh CR; Schöneich C
J Pharm Sci; 2022 Sep; 111(9):2435-2444. PubMed ID: 35716732
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous quantification of polysorbate 20 and poloxamer 188 in biopharmaceutical formulations using evaporative light scattering detection.
Paschen CA; Klemm D; Graf T; Kopf R; Pinto C; Müller C; Bell CH; Pfaff J
J Pharm Biomed Anal; 2021 Jan; 192():113640. PubMed ID: 33002754
[TBL] [Abstract][Full Text] [Related]
11. Determination of polysorbate 80 in parenteral formulations by high-performance liquid chromatography and evaporative light scattering detection.
Nair LM; Stephens NV; Vincent S; Raghavan N; Sand PJ
J Chromatogr A; 2003 Sep; 1012(1):81-6. PubMed ID: 14509344
[TBL] [Abstract][Full Text] [Related]
12. Controlled polysorbate 20 hydrolysis - A new approach to assess the impact of polysorbate 20 degradation on biopharmaceutical product quality in shortened time.
Graf T; Abstiens K; Wedekind F; Elger C; Haindl M; Wurth C; Leiss M
Eur J Pharm Biopharm; 2020 Jul; 152():318-326. PubMed ID: 32445968
[TBL] [Abstract][Full Text] [Related]
13. Dual Effect of Histidine on Polysorbate 20 Stability: Mechanistic Studies.
Zhang L; Yadav S; John Wang Y; Mozziconacci O; Schӧneich C
Pharm Res; 2018 Jan; 35(2):33. PubMed ID: 29368235
[TBL] [Abstract][Full Text] [Related]
14. Characterization of Polysorbate Ester Fractions and Implications in Protein Drug Product Stability.
Tomlinson A; Zarraga IE; Demeule B
Mol Pharm; 2020 Jul; 17(7):2345-2353. PubMed ID: 32442382
[TBL] [Abstract][Full Text] [Related]
15. Assessing the polysorbate degradation fingerprints and kinetics of lipases - how the activity of polysorbate degrading hydrolases is influenced by the assay and assay conditions.
Glücklich N; Carle S; Buske J; Mäder K; Garidel P
Eur J Pharm Sci; 2021 Nov; 166():105980. PubMed ID: 34419573
[TBL] [Abstract][Full Text] [Related]
16. Considerations for the Use of Polysorbates in Biopharmaceuticals.
Jones MT; Mahler HC; Yadav S; Bindra D; Corvari V; Fesinmeyer RM; Gupta K; Harmon AM; Hinds KD; Koulov A; Liu W; Maloney K; Wang J; Yeh PY; Singh SK
Pharm Res; 2018 May; 35(8):148. PubMed ID: 29797101
[TBL] [Abstract][Full Text] [Related]
17. Novel EDTA mediated ethanol protein precipitation method and the application for polysorbate quantification in high protein concentration biopharmaceuticals.
Halim VA; de Jonker M; Esteve C; Assenberg R; Balog C
J Pharm Biomed Anal; 2024 Aug; 245():116145. PubMed ID: 38631071
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of Super Refined™ Polysorbate 20 With Respect to Polysorbate Degradation, Particle Formation and Protein Stability.
Doshi N; Fish R; Padilla K; Yadav S
J Pharm Sci; 2020 Oct; 109(10):2986-2995. PubMed ID: 32679214
[TBL] [Abstract][Full Text] [Related]
19. Preservative Induced Polysorbate 80 Micelle Aggregation.
Gilbert PH; Zhang Z; Qian KK; Allen DP; Wagner NJ; Liu Y
J Pharm Sci; 2021 Jun; 110(6):2395-2404. PubMed ID: 33387597
[TBL] [Abstract][Full Text] [Related]
20. Polysorbate 20 Degradation in Biopharmaceutical Formulations: Quantification of Free Fatty Acids, Characterization of Particulates, and Insights into the Degradation Mechanism.
Tomlinson A; Demeule B; Lin B; Yadav S
Mol Pharm; 2015 Nov; 12(11):3805-15. PubMed ID: 26419339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
